2月3日,诺华制药(NVS.US)公布财报,公告显示公司2024财年净利润为119.41亿美元,同比增加39.37%;其中营业收入为503.17亿美元,同比增加10.73%,每股基本收益为5.92美元。从资产负债表来看,诺华制药(NVS.US)总负债626.37亿美元,其中短期债务83.24亿美元,资产负债比为0.01,流动比率为1.04。机构评级:截至2025年2月3日,当前有22家机构对诺华...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.